Pamela Yanchik Connealy
Chief Financial Officer
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2021-07-16
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Immunovant, Inc. (IMVT) | M.B.A. Chief Financial Officer | $393,000 | $5,602,705 |
| 2019 | Immunovant, Inc. (IMVT) | M.B.A. Chief Financial Officer | $147,618 | $2,775,934 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.